clinical trial

diverse group of adults
July 5, 2016

Vanderbilt establishes innovation center to boost demographic representation in clinical trial enrollment

Many clinical trials are stopped prematurely because they fail to recruit enough study participants. Vanderbilt University Medical Center has received a five-year, $14 million grant from the National Center for Advancing Translational Sciences at the National Institutes of Health to address this.

By Bill Snyder
April 14, 2016

First subject enrolled in international HIV prevention study

This month an international HIV prevention trial was launched that is testing the infection-preventing prowess of a monoclonal antibody called VRCO1.

By Paul Govern
February 23, 2016

VUMC study finds statins do not ease kidney injury following cardiac surgery

By Paul Govern
research default banner
November 5, 2015

Initiative speeds clinical trials contract negotiations

An initiative promoted by the Vanderbilt Institute of Clinical and Translational Research (VICTR) offers an opportunity to reduce by more than half the time it takes to negotiate clinical trial contracts.

By Bill Snyder
Insulin in vials
September 10, 2015

Diabetes trial targets body’s ability to produce insulin

Kiersten Eaddy had long looked forward to her high school graduation day and joining her classmates to celebrate the accomplishment.

By VUMC News and Communications
March 26, 2015

ResearchMatch adds new clinical trials feature

Patients seeking to participate in clinical trials have a new option in online tools for finding studies that might offer hope for their problem or condition.

By Paul Govern
February 25, 2015

Vanderbilt to study use of plasma on LifeFlight, extends trial to Rutherford County base

By VUMC News and Communications
February 12, 2015

VU study explores optimal timing for pertussis vaccine

Pertussis, commonly known as whooping cough, is experiencing a resurgence, and its tiniest victims are not armed to battle the contagious respiratory infection.
By Jessica Pasley
April 3, 2014

DBS for Parkinson’s trial moves to next level

A long-term Vanderbilt University Medical Center study of deep brain stimulation (DBS) in early-stage Parkinson’s disease has received approval from the Food and Drug Administration (FDA) to continue in a pivotal, phase III, large-scale safety and efficacy trial.
By VUMC News and Communications
November 14, 2013

Heart Institute studying absorbable coronary stent

Vanderbilt Heart and Vascular Institute is participating in a clinical trial to evaluate a medical device for the treatment of coronary artery disease.
By Kathy Whitney
October 29, 2013

Vanderbilt to study use of plasma on LifeFlight

Vanderbilt University Medical Center will participate in a national trial to see if outcomes for critically injured patients with uncontrolled bleeding can be improved by administering plasma to these patients while in flight to the hospital.
By VUMC News and Communications
October 24, 2013

Glucose control study gives patients new path to health

The IDIOM study is designed to compare how a diet with moderate caloric restriction, alone or with long-acting insulin, affects areas of the brain’s dopamine system that are involved in food intake, reward and the sense of pleasure people get from eating.
By Jessica Pasley
September 12, 2013

VU tracking drug’s ability to prevent type 1 diabetes

Vanderbilt’s Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D.
By VUMC News and Communications